Supriya Lifescience Ltd. Achieves Impressive 19% Revenue Growth Year-Over-Year in Q2 FY25
Mumbai, 30th October 2024: The unaudited financial statements for the Q2FY25 results have been released by Supriya Lifescience Ltd., a cGMP-compliant business with a strong track record in API manufacturing…